9 The M&A exit from science-based firms

Mattia Cattaneo, Michele Meoli, Stefano Paleari and Silvio Vismara

 

Abstract

This chapter investigates the valuation and M&A dynamics of the population of 254 biotech firms that went public in Europe over the last two decades. Among these, we identify a high proportion (40 per cent) of firms affiliated with a university or another public research organization. After controlling for intellectual capital and other possible determinants, we find that the affiliation with a university is recognized as beneficial by investors and enhances the propensity of being targeted in subsequent M&A deals. Our message is that IPOs and acquisitions by incumbent firms are mechanisms to complete the technology transfer process ...

Get Entrepreneurial Knowledge, Technology and the Transformation of Regions now with the O’Reilly learning platform.

O’Reilly members experience books, live events, courses curated by job role, and more from O’Reilly and nearly 200 top publishers.